Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Category list : Antirheumatic agents

Sort by: Newest first Oldest first A-Z Z-A

  • Adding etanercept to MTX improves early remission

    16 JUL 2008 17:11

    Patients with early severe rheumatoid arthritis (RA) have a greater chance of remission in the first year of therapy if treated with combined methotrexate and tumour necrosis factor (TNF) inhibitor, a trial published online on 16 July 2008 in The Lancet suggests.

  • Egyptian prescribing

    Pharaohs and the first prescriptions Subscription

    22 DEC 2007 0:00

    Almost 1,500 years before the Magi brought gifts of frankincense and myrrh to Bethlehem, the ancient Egyptians included them among their vast materia medica. Some 2,000 prescriptions are recorded.

  • Data fail to show differences in efficacy of arthritis regimens

    24 NOV 2007 0:00

    There is no firm evidence that any one regimen for rheumatoid arthritis is better than any other, according to a systematic review published online this week in Annals of Internal Medicine (20 November 2007).

  • Anti-TNFs accepted by NICE for rheumatoid arthritis

    26 OCT 2007 23:00

    Sue McDonald/iStockphoto Rheumatoid arthritis: adalimumab added to drug arsenal

  • Oncology drugs accepted by SMC

    25 NOV 2006 0:00

    Steve Gschmeissner/Science Photo Library Chronic lymphocytic leukaemia can be treated with fludarabine

  • Use omalizumab only within trials

    11 NOV 2006 0:00

    Omalizumab should only be used in the context of clinical trials, according to the latest edition of the Drug and Therapeutics Bulletin (2006;44:86).

  • Uncertainty remains over TNF inhibitors and risk of cancer

    1 SEP 2006 23:00

    Patients receiving tumour necrosis factor (TNF) inhibitors for rheumatoid arthritis are not at substantially greater risk of cancer than those receiving methotrexate, researchers have found. The findings appear to clash with other research suggesting a greater

  • SPC changes / Prescription products / Supply issues / Products miscellany

    21 JUL 2006 23:00

    Prescription Products Amphocil Amphocil (amphotericin B as a complex with sodium cholesteryl sulphate) lyophilisate for reconstitution is now available from Beacon Pharmaceuticals. Net price: 1 x 50mg vial, £104.10; 1 x 100mg vial, £190.05. Legal category: POM.

  • Abatacept continues to show benefits for rheumatoid arthritis

    14 JUL 2006 23:00

    Positive results continue to emerge for abatacept, the first in a new class of drugs for rheumatoid arthritis that selectively modulates the co-stimulatory signal required for full T-cell activation. A study published in the Annals

  • SMC issues guidance on six more drugs

    17 DEC 2005 0:00

    The Scottish Medicines Consortium this week accepted five drugs for use within NHS Scotland and rejected one.

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.